Cargando…
P1174: THE COMBINATION OF QUALITATIVE AND QUANTITATIVE METABOLIC PARAMETERS PREDICTS PROGRESSION-FREE SURVIVAL IN PATIENTS WITH LARGE B-CELL LYMPHOMAS (LBCL) TREATED WITH ANTI-CD19 CAR-T CELLS.
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430247/ http://dx.doi.org/10.1097/01.HS9.0000847560.15177.a7 |
| _version_ | 1784779708520464384 |
|---|---|
| author | Dodero, A. Guidetti, A. Lorenzoni, A. Pizzamiglio, S. Argiroffi, G. Verderio, P. Chiappella, A. Bagnoli, F. Carniti, C. Pennisi, M. Alessi, A. Corradini, P. |
| author_facet | Dodero, A. Guidetti, A. Lorenzoni, A. Pizzamiglio, S. Argiroffi, G. Verderio, P. Chiappella, A. Bagnoli, F. Carniti, C. Pennisi, M. Alessi, A. Corradini, P. |
| author_sort | Dodero, A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9430247 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94302472022-08-31 P1174: THE COMBINATION OF QUALITATIVE AND QUANTITATIVE METABOLIC PARAMETERS PREDICTS PROGRESSION-FREE SURVIVAL IN PATIENTS WITH LARGE B-CELL LYMPHOMAS (LBCL) TREATED WITH ANTI-CD19 CAR-T CELLS. Dodero, A. Guidetti, A. Lorenzoni, A. Pizzamiglio, S. Argiroffi, G. Verderio, P. Chiappella, A. Bagnoli, F. Carniti, C. Pennisi, M. Alessi, A. Corradini, P. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430247/ http://dx.doi.org/10.1097/01.HS9.0000847560.15177.a7 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Dodero, A. Guidetti, A. Lorenzoni, A. Pizzamiglio, S. Argiroffi, G. Verderio, P. Chiappella, A. Bagnoli, F. Carniti, C. Pennisi, M. Alessi, A. Corradini, P. P1174: THE COMBINATION OF QUALITATIVE AND QUANTITATIVE METABOLIC PARAMETERS PREDICTS PROGRESSION-FREE SURVIVAL IN PATIENTS WITH LARGE B-CELL LYMPHOMAS (LBCL) TREATED WITH ANTI-CD19 CAR-T CELLS. |
| title | P1174: THE COMBINATION OF QUALITATIVE AND QUANTITATIVE METABOLIC PARAMETERS PREDICTS PROGRESSION-FREE SURVIVAL IN PATIENTS WITH LARGE B-CELL LYMPHOMAS (LBCL) TREATED WITH ANTI-CD19 CAR-T CELLS. |
| title_full | P1174: THE COMBINATION OF QUALITATIVE AND QUANTITATIVE METABOLIC PARAMETERS PREDICTS PROGRESSION-FREE SURVIVAL IN PATIENTS WITH LARGE B-CELL LYMPHOMAS (LBCL) TREATED WITH ANTI-CD19 CAR-T CELLS. |
| title_fullStr | P1174: THE COMBINATION OF QUALITATIVE AND QUANTITATIVE METABOLIC PARAMETERS PREDICTS PROGRESSION-FREE SURVIVAL IN PATIENTS WITH LARGE B-CELL LYMPHOMAS (LBCL) TREATED WITH ANTI-CD19 CAR-T CELLS. |
| title_full_unstemmed | P1174: THE COMBINATION OF QUALITATIVE AND QUANTITATIVE METABOLIC PARAMETERS PREDICTS PROGRESSION-FREE SURVIVAL IN PATIENTS WITH LARGE B-CELL LYMPHOMAS (LBCL) TREATED WITH ANTI-CD19 CAR-T CELLS. |
| title_short | P1174: THE COMBINATION OF QUALITATIVE AND QUANTITATIVE METABOLIC PARAMETERS PREDICTS PROGRESSION-FREE SURVIVAL IN PATIENTS WITH LARGE B-CELL LYMPHOMAS (LBCL) TREATED WITH ANTI-CD19 CAR-T CELLS. |
| title_sort | p1174: the combination of qualitative and quantitative metabolic parameters predicts progression-free survival in patients with large b-cell lymphomas (lbcl) treated with anti-cd19 car-t cells. |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430247/ http://dx.doi.org/10.1097/01.HS9.0000847560.15177.a7 |
| work_keys_str_mv | AT doderoa p1174thecombinationofqualitativeandquantitativemetabolicparameterspredictsprogressionfreesurvivalinpatientswithlargebcelllymphomaslbcltreatedwithanticd19cartcells AT guidettia p1174thecombinationofqualitativeandquantitativemetabolicparameterspredictsprogressionfreesurvivalinpatientswithlargebcelllymphomaslbcltreatedwithanticd19cartcells AT lorenzonia p1174thecombinationofqualitativeandquantitativemetabolicparameterspredictsprogressionfreesurvivalinpatientswithlargebcelllymphomaslbcltreatedwithanticd19cartcells AT pizzamiglios p1174thecombinationofqualitativeandquantitativemetabolicparameterspredictsprogressionfreesurvivalinpatientswithlargebcelllymphomaslbcltreatedwithanticd19cartcells AT argiroffig p1174thecombinationofqualitativeandquantitativemetabolicparameterspredictsprogressionfreesurvivalinpatientswithlargebcelllymphomaslbcltreatedwithanticd19cartcells AT verderiop p1174thecombinationofqualitativeandquantitativemetabolicparameterspredictsprogressionfreesurvivalinpatientswithlargebcelllymphomaslbcltreatedwithanticd19cartcells AT chiappellaa p1174thecombinationofqualitativeandquantitativemetabolicparameterspredictsprogressionfreesurvivalinpatientswithlargebcelllymphomaslbcltreatedwithanticd19cartcells AT bagnolif p1174thecombinationofqualitativeandquantitativemetabolicparameterspredictsprogressionfreesurvivalinpatientswithlargebcelllymphomaslbcltreatedwithanticd19cartcells AT carnitic p1174thecombinationofqualitativeandquantitativemetabolicparameterspredictsprogressionfreesurvivalinpatientswithlargebcelllymphomaslbcltreatedwithanticd19cartcells AT pennisim p1174thecombinationofqualitativeandquantitativemetabolicparameterspredictsprogressionfreesurvivalinpatientswithlargebcelllymphomaslbcltreatedwithanticd19cartcells AT alessia p1174thecombinationofqualitativeandquantitativemetabolicparameterspredictsprogressionfreesurvivalinpatientswithlargebcelllymphomaslbcltreatedwithanticd19cartcells AT corradinip p1174thecombinationofqualitativeandquantitativemetabolicparameterspredictsprogressionfreesurvivalinpatientswithlargebcelllymphomaslbcltreatedwithanticd19cartcells |